+ Filter
Loading...
Custom Services order now ship next day

Anti-ICOS Recombinant Antibody Products

Loading...

Anti-ICOS Products

More Infomation

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs provides an extensive selection of high-quality anti-ICOS recombinant antibodies, which are meticulously engineered to ensure superior performance. Utilizing our advanced platform, we guarantee exceptional specificity, stability, and efficacy in all our products. These attributes make our antibodies invaluable assets for researchers and developers engaged in the field of targeted cancer therapy. By employing our state-of-the-art technology, we are committed to aiding scientific advancement and enhancing the outcomes of cancer treatment strategies.

ICOS: A Versatile Immunotherapeutic Target

Inducible T-cell co-stimulator (ICOS, CD278), a member of the CD28 family, is upregulated upon T cell receptor (TCR) and/or CD28 co-stimulation. While its role in Th1 immunity remains debated, ICOS promotes Th2 responses. Critically, ICOS is essential for the development, survival, and follicular localization of T follicular helper (Tfh) cells, which are crucial for driving antibody affinity maturation within germinal centers. Given its influence on these key aspects of T cell function, ICOS significantly impacts the pathogenesis of numerous human diseases.

Alternative Names

AILIM; CD278; CVID1; inducible T-cell co-stimulator; inducible T-cell costimulatory; inducible T cell costimulatory; activation-inducible lymphocyte immunomodulatory molecule.

Background

The protein encoded by this gene belongs to the CD28 and CTLA-4 cell-surface receptor family. It forms homodimers and plays an important role in cell-cell signaling, immune responses, and regulation of cell proliferation.

Anti-ICOS rAb Products

Creative Biolabs provides a comprehensive portfolio of recombinant anti-ICOS antibodies, meticulously engineered with exceptional specificity and affinity. Available in a variety of formats, these antibodies are designed to serve a wide range of research and therapeutic applications, from fundamental investigations in immunology and cancer biology to the development of novel treatments. Leveraging our advanced platform, we offer cutting-edge tools that empower researchers to accelerate their work. These tools include high-quality antibodies for applications such as FC, ELISA, and WB, as well as for therapeutic development. By providing these state-of-the-art reagents, Creative Biolabs supports the advancement of scientific understanding and the development of innovative therapies to address critical unmet medical needs.

Table 1. Featured anti-ICOS recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
HPAB-0111-CN Human Anti-ICOS Recombinant Antibody (HPAB-0111-CN) Human Humanized IgG ELISA, FC, IHC
HPAB-0052-YJ-S(P) Human Anti-ICOS Recombinant Antibody (clone JMab-136); scFv Fragment Human, Mouse, Rat Human scFv ELISA
TAB-128CT Mouse Anti-ICOS Recombinant Antibody (TAB-128CT) Human Mouse IgG ELISA, WB
HPAB-0073-WJ Human Anti-ICOS Recombinant Antibody (HPAB-0073-WJ) Human Human IgG ELISA, IHC, Inhib, FC
HPAB-0110-CN Hamster Anti-ICOS Recombinant Antibody (HPAB-0110-CN) Human, Mouse, Rat, Cynomolgus Hamster IgG ELISA, FC, IHC

Creative Quality Control

Creative Biolabs employs rigorous quality control measures throughout the entire production and characterization process of anti-ICOS recombinant antibodies. This includes stringent screening for specificity, affinity, and purity using advanced techniques. We meticulously validate antibody performance in relevant applications, providing consistent and trustworthy outcomes to our consumers. Our commitment to quality ensures that researchers receive high-quality reagents that meet their specific needs and accelerate their research progress.

Fig.1 WB analysis. (Creative Biolabs Original)Fig.1 WB analysis of anti-ICOS antibody, scFv Fragment.
(Cat# HPAB-0052-YJ-S(P), Creative Biolabs).

Fig.2 ELISA analysis. (Creative Biolabs Original)Fig.2 ELISA analysis of anti-ICOS antibody, scFv Fragment.
(Cat# HPAB-0052-YJ-S(P), Creative Biolabs).

Fig.3 DB analysis. (Creative Biolabs Original)Fig.3 DB analysis of anti-ICOS antibody, scFv Fragment.
(Cat# HPAB-0052-YJ-S(P), Creative Biolabs).

Fig.4 WB analysis. (Creative Biolabs Original)Fig.4 WB analysis of anti-ICOS antibody.
(Cat# TAB-128CT, Creative Biolabs).

Fig.5 WB analysis. (Creative Biolabs Original)Fig.5 WB analysis of anti-ICOS antibody.
(Cat# HPAB-0111-CN, Creative Biolabs).

Fig.6 WB analysis. (Creative Biolabs Original)Fig.6 WB analysis of anti-ICOS antibody.
(Cat# HPAB-0111-CN, Creative Biolabs).

Customer Reviews

Excellent
Ri***r
Human Anti-ICOS Recombinant Antibody (HPAB-0111-CN) (HPAB-0111-CN)
I was initially skeptical about finding an anti-ICOS antibody with the sensitivity I needed for my flow cytometry experiments. However, the Creative Biolabs antibody exceeded my expectations. It specifically stained my target cells with minimal background noise, allowing me to clearly distinguish ICOS expression levels. The high sensitivity enabled me to analyze even low-expressing cell populations, which was crucial for my research.
16/May/2021
Excellent
Ab***l
Mouse Anti-ICOS Recombinant Antibody (TAB-128CT) (TAB-128CT)
I've been using Creative Biolabs' anti-ICOS antibody in my lab for over a year now, and I've consistently obtained reliable and reproducible results. The antibody performs consistently across different experimental conditions, which is essential for my ongoing research. The high quality of the antibody has saved me significant time and effort in troubleshooting experiments.
11/Sep/2022
Excellent
Ro***l
Human Anti-ICOS Recombinant Antibody (HPAB-0073-WJ) (HPAB-0073-WJ)
I encountered a minor issue with one of the antibody batches. When I reached out to the technical support staff at Creative Biolabs, they were very accommodating and quick to respond. They quickly addressed my concerns and provided valuable troubleshooting advice. Their professionalism and dedication to customer satisfaction were greatly valued.
10/Nov/2023

rAb Production

Creative Biolabs offers high-quality anti-ICOS antibodies, leveraging advanced genetic technologies for reliable and consistent production.

Featured Anti-ICOS Recombinant Antibody Production PlatformsFig.7 Milligram-scale. (Creative Biolabs Original)
Fig.7 Milligram-scale anti-ICOS recombinant antibody production.

Fig.8 Gram-scale. (Creative Biolabs Original)Fig.8 Gram-scale anti-ICOS recombinant antibody production.

rAb Modalities

Creative Biolabs delivers a diverse selection of top-tier anti-ICOS recombinant antibodies, designed in various formats to cater to the unique needs of researchers worldwide.

Fig.9 ICOS antibody production and modalities. (Creative Biolabs Original)Fig.9 Full-length anti-ICOS recombinant antibody production and modalities.

ICOS-Targeted Drug Information

Table 2. Public drug targeting ICOS.

Company Research Phase Classification Condition
AbbVie
Alpine Immune Sciences (Originator)
Phase II Fc Fusion Proteins
Polypeptides, from 41 AA
Arthritis
Arthritis, psoriatic
Autoimmune disease
Encephalomyelitis, autoimmune
Graft-versus-host disease
Inflammatory bowel disease
Inflammatory disorders
Systemic lupus erythematosus
Celgene
Jounce Therapeutics (Originator)
Phase II Agonist Antibodies
Cancer Immunotherapy
Humanized Monoclonal Antibodies
Cancer
Cancer, bladder (urothelial carcinoma)
Cancer, head and neck (squamous cell carcinoma)
Cancer, lung (non-small cell) (NSCLC)
Cancer, solid tumor
Cancer, stomach
Melanoma
Triple negative breast cancer
Bristol-Myers Squibb (Originator) Phase I/II Agonist Antibodies
Cancer Immunotherapy
Monoclonal Antibodies
Cancer, solid tumor
Xencor (Originator) Phase I Bispecific Antibodies
Cancer Immunotherapy
Monoclonal Antibodies
Cancer, solid tumor
AstraZeneca (Originator)
MedImmune (AstraZeneca)
National Cancer Institute
National Cancer Institute (NCI) (National Cancer Institute)
Phase I Cancer Immunotherapy
Monoclonal Antibodies
Peripheral T-cell lymphoma
Systemic lupus erythematosus
Kymab (Sanofi)
Sanofi (Originator)
Discontinued Cancer Immunotherapy
Human Monoclonal Antibodies
Cancer, solid tumor
GlaxoSmithKline (GSK)
GSK (Originator)
INSERM (Originator)
Discontinued Agonist Antibodies
Cancer Immunotherapy
Humanized Monoclonal Antibodies
Cancer, head and neck (squamous cell carcinoma)
Cancer, kidney (renal cell carcinoma, clear cell)
Cancer, lung (non-small cell) (NSCLC)
Cancer, prostate (castration-resistant)
Cancer, solid tumor
Genitourinary cancer
Melanoma
Multiple myeloma
Korea Advanced Institute Science Technol (Originator)
Yonsei University College Medicine (Originator)
Preclinical Monoclonal Antibodies Pemphigus vulgaris
Universidad de Navarra (Originator) Preclinical Aptamers
Peptides
Cancer
Sanofi (Originator) Preclinical Agonist Antibodies
Bispecific Antibodies
Cancer Immunotherapy
Human Monoclonal Antibodies
Cancer

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

As a leading supplier in the antibody industry, Creative Biolabs is equipped with high-standard antibody production processes and a professional technical team to ensure high-quality product supply. If you are interested in our anti-ICOS recombinant antibody products, please feel free to contact us for more details.

Go to compare

Go to compare